Characterization of COVID-19 Vaccine Clinical Trial Discussions on the Social Question-and-Answer Site Quora

Author:

Xu Qing1,McMann Tiana J.2,Li Jiawei1,Wenzel Christine1,Mackey Tim Ken3ORCID

Affiliation:

1. S-3 Research LLC

2. University of California San Diego

3. University of California, San Diego

Abstract

Abstract Introduction: Throughout the COVID-19 pandemic underserved populations, such as racial and ethnic minorities, were disproportionately impacted by illness, hospitalization, and death. Equity in clinical trials means that the participants in clinical trials represent the people who are most likely to have the health condition and need the treatment that the trial is testing. Infodemiology approaches examining user conversations on social media platforms have the potential to elucidate specific barriers and challenges related to clinical trial participation. Methodology: The study retrospectively collected and analyzed user question and answer posts from Quora in October 2021 using an inductive content coding approach. We also examined user’s publicly available profile metadata to identify racial and ethnic minority populations to capture their experiences, attitudes, topics, and barriers to COVID-19 vaccine trials. Result A total of 1,073 questions and 7,479 answers were collected based on structured automated keyword queries and data mining. A total of 763 questions and 2,548 answers were identified as related to COVID-19 vaccine clinical trials. The majority of these online interactions focused on asking questions and sharing knowledge and opinions about COVID-19 vaccine trials, including major topics related to: (a) interpreting whether clinical trial results could be trusted; (b) questions about vaccine efficacy and safety; (c) understanding trial design, regulatory considerations, and vaccine platforms; and (d) questions about trial enrollment, length, and adequate representation. Additionally, four major barriers discussed included: (i) disagreement from users regarding whether clinical trials require representation from different racial and ethnic minorities; (ii) concerns regarding the safety of trials when participating; (iii) lack of knowledge on how to register for a trial; and (iv) whether participants could withdraw from a trial to receive a more rapidly approved COVID-19 vaccine. Conclusions Our study found active user discussions related to COVID-19 vaccine clinical trials on Quora, including those specific to minority health topics and posted by self-identified racial and ethnic minority online users. Results from this study can help identify near real-time barriers to participation among underrepresented groups and support the design of future outreach strategies to help with recruitment and inclusive participation.

Publisher

Research Square Platform LLC

Reference21 articles.

1. COVID-19 Map. - Johns Hopkins Coronavirus Resource Center [Internet]. [cited 2021 Jul 30]. Available from: https://coronavirus.jhu.edu/map.html.

2. “Midwife’s mandarin madness”: walking the Great Wall of China for charity;Sidebotham M;J Fam Heal Care,2002

3. Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region — United States, March–December 2020;Romano SD;Morbidity Mortal Wkly Rep,2021

4. Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity | CDC [Internet]. [cited 2022 Jun 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html.

5. Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021;Acosta AM;Jama Netw Open,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3